Clin Pharmacol (2014) 6:1619.10.2147/CPAA.S70707 71 DaidoneFMontioliRPaiardiniACelliniBMacchiaruloAGiardinaGet alIdentification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors
10.1074/jbc.M805459200 87 SwitzerC
Rawshani A, Rawshani A, Franzn S, et al
One path, two solutions: network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disorders

Tridecyl Trimellitate, Octyldodecanol, Polyisobutene, Polyglyceryl-3 Diisostearate, Candelilla Cera/Euphorbia Cerifera (Candelilla) Wax/Cire de Candelilla, Cera Carnauba/Copernicia Cerifera (Carnauba) Wax/Cire de Carnauba, Behenyl Behenate, Polyhydroxystearic Acid, Mentha Arvensis Leaf Oil, Persea Gratissima (Avocado) Oil, Butyrospermum Parkii (Shea) Butter, Helianthus Annuus (Sunflower) Seed Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Plukenetia Volubilis Seed Oil, Ricinus Communis (Castor) Seed Oil, Sodium Hyaluronate, Hydrogenated Castor Oil, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Tocopheryl Acetate, Ethylhexyl Palmitate, Tribehenin, Sorbitan Isostearate, Lactic Acid, Palmitoyl Tripeptide-1, Tocopherol, Phenoxyethanol, Limonene, Aluminum Hydroxide, Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499), Red 7 (CI 15850)
Further investigation is required to determine the net impact of GLP-1RAs on TAMs and tumor outcomes